
Gabriel Lazaro-Munoz
@GLMbioethics
Followers
1K
Following
1K
Media
76
Statuses
1K
Associate Professor @HarvardMed @MGHNeurosurg & @MGHPsychiatry Bioethicist, Neuroscientist, Lawyer. Ethical and social implications of genomics & neuroscience
Boston, MA
Joined September 2017
We just published this paper in Genetics in Medicine examining how different populations view and use the concept of "eugenics" when discussing polygenic embryo screening. EUGENICS AND POLYGENIC EMBRYO SCREENING...
1
3
12
Associated Press article on the challenges patients with treatment-resistant conditions face when trying to maintain beneficial experimental neural devices, once trials end. With quotes from the brilliant and inspiring Brandy Ellis. #neurotechjustice
https://t.co/eplCtVZkUO
apnews.com
People with experimental brain implants often turn to the treatment as a last resort, hoping to improve their health when everything else has failed.
0
0
0
EUGENICS AND POLYGENIC EMBRYO SCREENING: PUBLIC, CLINICIAN, AND PATIENT PERCEPTIONS OF CONDITIONS VERSUS TRAITS Led by Dorit Barlevy and @RemyFurrer with co-authors @ShaiCarmi @ToddLencz and @SPereira_PhD
0
0
3
Would you consider using these neurotechnologies if you were experiencing severe mood, memory, or motor symptoms? Here’s how 1000+ U.S participants responded when asked that exact question. Collaborators: @armerner_psych @GLMbioethics @Twilli7 @MGBneurosurgery @MGBResearchNews
1
1
4
It takes a coalition to build visionary new programs. It was fantastic this past year to work with Dr. Marcela del Carmen, President of @MassGeneralNews and @MassGeneralMDs and @dana_fdn President and CEO Caroline Montogo to create a framework for supporting next generation
0
6
21
Highlights of 2024: One of the exciting initiatives for me as chair of @MGBneurosurgery this past year, was witnessing the launch of NJAM, the Neurotech Justice Accelerator at Mass General Brigham, @MassGeneralNews led by neurosurgeon Theresa Williamson MD MPH @Twilli7, Gabriel
NJAM Senior Fellows will receive mentorship and training from NJAM Director Dr. Theresa Williamson MD MPH @Twilli7, as well as NJAM Co-Directors Dr. Gabriel Lázaro Muñoz PhD JD @GLMbioethics and Dr. Francis Shen JD PhD
1
8
22
NJAM Senior Fellows will receive mentorship and training from NJAM Director Dr. Theresa Williamson MD MPH @Twilli7, as well as NJAM Co-Directors Dr. Gabriel Lázaro Muñoz PhD JD @GLMbioethics and Dr. Francis Shen JD PhD
dana.org
1
2
5
📢Job Alert: Join the Neurotech Justice Accelerator at Mass General Brigham (NJAM), a @dana_fdn Center for Neuroscience and Society. NJAM will provide a forum and training ground to reimagine the future of #neurotechnology in society. Learn more 👇 (1/3)
1
5
8
excited to share our paper on bioethics & nsgy in @WorldNeurosurg the idea of this paper was born 2 yrs ago, great to see it published! team: @white_sasha_j @Twilli7 @BrianNahed @stephenpmiranda @GLMbioethics @drpouratian @MariamA_2023 @HMSbioethics
https://t.co/jMQDaeXp8s
3
15
79
Congratulations to Ana Lucía Battaglino, MA and Erika Versalovic, PhD, researchers in our @GLMbioethics Brain Bioethics Laboratory, for their award-winning work at @neuroethicsinfo's Annual Meeting! https://t.co/W2HLBtS9o5
#HMSBioethics
0
1
5
Excited to see the DBS Think Tank proceedings out, including the @GLMbioethics lab's continued work on post-trial obligations and @Twilli7's work on DBS access disparities!
The Deep Brain Stimulation (DBS) Think Tank XI proceedings is published! “Pushing the Forefront of Neuromodulation,” the updates, paper and meeting were highlighted by @ndosenbach who presented research recently published in @Nature w/Evan Gordon to identify and characterize the
0
4
14
Meet junior neuroethicist Amanda Merner in this short series of a Day in the Life of a Neuroethicist https://t.co/yoyJ4tRgJX
#blog #ethics #academia #career #neuroscience #brain
1
4
14
We are delighted to present this original research in our special issue on NeuroRights. Ethical Considerations for Integrating Multimodal Computer Perception and Neurotechnology. https://t.co/KUEhrIjO4A Congratulations to @GLMbioethics and team at @HMSbioethics @MGHPsychiatry
1
3
7
We are pleased to announce the publication of a new addition to ELSIhub Collections: Screening Embryos for Psychiatric Conditions: Public Perspectives, Ethical and Social Issues, edited by @GLMbioethics and @armerner_psych. Read here:
0
2
3
Read comment from @CohenProf in "Genetic testing of embryos: An ethical debate unfolds" https://t.co/Qawz0pzUe6 via @BostonGlobe
bostonglobe.com
We’re still far from "Brave New World" or "Gattaca" but also closer than you may think.
1
3
10
.@SusieHuangMDPhD & colleagues are working to increase diversity in the recruitment and enrollment of human participants in neuroscience research, & thus to ensure that the benefits of the research are shared equitably. https://t.co/BKF7vG2Z8e
@mghclbb @MGHCAREResearch @MGH_RI
1
5
33
Today is the launch of my new book. It was fun to do. As always, you learn a lot by writing. Thanks Harvard University Press. Great working with. You can read about the book here https://t.co/1owHHG4FsL...
13
62
328
New commentary from me & @CynthiaKubuPhD about the impacts of speculative neuroethics research including: increasing stigma surrounding brain implants, stoking fears among potential patients, and deterring adoption of the technology. https://t.co/2RUxEp17qw
tandfonline.com
Published in AJOB Neuroscience (Vol. 14, No. 4, 2023)
0
4
5
ANOTHER NEW PREPRINT! In a nationally representative survey (n=1435), we find high approval for polygenic embryo screening. In a separate sample, presenting concerns first increased ambivalence but not disapproval. Work led by @RemyFurrer & @GLMbioethics
medrxiv.org
Polygenic embryo screening (PES) is a novel – yet commercially available – technology that can compute genetic likelihood estimates of polygenic conditions (e.g., diabetes, depression) and traits...
1
16
27
Excited to share two preprints on stakeholder attitudes towards polygenic embryo screening (PES). Takeaways: * The (US) public and IVF patients approve PES and some are interested. * Fertility clinicians have many concerns and most don't plan to offer PES. 🧵below.
1
10
29